A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.

Interleukin (IL) 33, a member of IL-1 cytokine family, is well known to promote Th2 type immune responses by signaling through its receptor ST2. However, it is not clear whether ST2 is expressed by mucosal epithelium, and how it responds to IL-33 to induce inflammatory mediators. This study was to i...

Full description

Bibliographic Details
Main Authors: Jing Lin, Lili Zhang, Guiqiu Zhao, Zhitao Su, Ruzhi Deng, Stephen C Pflugfelder, De-Quan Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3622010?pdf=render
id doaj-a2568cbbed3c4929936c1c0c574d4d03
record_format Article
spelling doaj-a2568cbbed3c4929936c1c0c574d4d032020-11-24T21:51:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6096310.1371/journal.pone.0060963A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.Jing LinLili ZhangGuiqiu ZhaoZhitao SuRuzhi DengStephen C PflugfelderDe-Quan LiInterleukin (IL) 33, a member of IL-1 cytokine family, is well known to promote Th2 type immune responses by signaling through its receptor ST2. However, it is not clear whether ST2 is expressed by mucosal epithelium, and how it responds to IL-33 to induce inflammatory mediators. This study was to identify the presence and function of ST2 and explore the role of IL-33/ST2 signaling in regulating the inflammatory cytokine production in corneal epithelial cells. Human corneal tissues and cultured primary human corneal epithelial cells (HCECs) were treated with IL-33 in different concentrations without or with different inhibitors to evaluate the expression, location and signaling pathways of ST2 in regulating production of inflammatory cytokine and chemokine. The mRNA expression was determined by reverse transcription and real time PCR, and protein production was measured by enzyme-linked immunosorbent assay (ELISA), immunohistochemical and immunofluorescent staining. ST2 mRNA and protein were detected in donor corneal epithelium and cultured HCECs, and ST2 signal was enhanced by exposure to IL-33. IL-33 significantly stimulated the production of inflammatory cytokines (TNF-α, IL-1β and IL-6) and chemokine IL-8 by HCECs at both mRNA and protein levels. The stimulated production of inflammatory mediators by IL-33 was blocked by ST2 antibody or soluble ST2 protein. Interestingly, the IκB-α inhibitor BAY11-7082 or NF-κB activation inhibitor quinazoline blocked NF-κB p65 protein phosphorylation and nuclear translocation, and also suppressed the production of these inflammatory cytokines and chemokine induced by IL-33. These findings demonstrate that ST2 is present in human corneal epithelial cells, and IL-33/ST2 signaling plays an important role in regulating IL-33 induced inflammatory responses in ocular surface.http://europepmc.org/articles/PMC3622010?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Jing Lin
Lili Zhang
Guiqiu Zhao
Zhitao Su
Ruzhi Deng
Stephen C Pflugfelder
De-Quan Li
spellingShingle Jing Lin
Lili Zhang
Guiqiu Zhao
Zhitao Su
Ruzhi Deng
Stephen C Pflugfelder
De-Quan Li
A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
PLoS ONE
author_facet Jing Lin
Lili Zhang
Guiqiu Zhao
Zhitao Su
Ruzhi Deng
Stephen C Pflugfelder
De-Quan Li
author_sort Jing Lin
title A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
title_short A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
title_full A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
title_fullStr A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
title_full_unstemmed A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
title_sort novel interleukin 33/st2 signaling regulates inflammatory response in human corneal epithelium.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Interleukin (IL) 33, a member of IL-1 cytokine family, is well known to promote Th2 type immune responses by signaling through its receptor ST2. However, it is not clear whether ST2 is expressed by mucosal epithelium, and how it responds to IL-33 to induce inflammatory mediators. This study was to identify the presence and function of ST2 and explore the role of IL-33/ST2 signaling in regulating the inflammatory cytokine production in corneal epithelial cells. Human corneal tissues and cultured primary human corneal epithelial cells (HCECs) were treated with IL-33 in different concentrations without or with different inhibitors to evaluate the expression, location and signaling pathways of ST2 in regulating production of inflammatory cytokine and chemokine. The mRNA expression was determined by reverse transcription and real time PCR, and protein production was measured by enzyme-linked immunosorbent assay (ELISA), immunohistochemical and immunofluorescent staining. ST2 mRNA and protein were detected in donor corneal epithelium and cultured HCECs, and ST2 signal was enhanced by exposure to IL-33. IL-33 significantly stimulated the production of inflammatory cytokines (TNF-α, IL-1β and IL-6) and chemokine IL-8 by HCECs at both mRNA and protein levels. The stimulated production of inflammatory mediators by IL-33 was blocked by ST2 antibody or soluble ST2 protein. Interestingly, the IκB-α inhibitor BAY11-7082 or NF-κB activation inhibitor quinazoline blocked NF-κB p65 protein phosphorylation and nuclear translocation, and also suppressed the production of these inflammatory cytokines and chemokine induced by IL-33. These findings demonstrate that ST2 is present in human corneal epithelial cells, and IL-33/ST2 signaling plays an important role in regulating IL-33 induced inflammatory responses in ocular surface.
url http://europepmc.org/articles/PMC3622010?pdf=render
work_keys_str_mv AT jinglin anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT lilizhang anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT guiqiuzhao anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT zhitaosu anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT ruzhideng anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT stephencpflugfelder anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT dequanli anovelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT jinglin novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT lilizhang novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT guiqiuzhao novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT zhitaosu novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT ruzhideng novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT stephencpflugfelder novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
AT dequanli novelinterleukin33st2signalingregulatesinflammatoryresponseinhumancornealepithelium
_version_ 1725878459925790720